Table 1 Respondents in the study
Data collection | Sample | |
|---|---|---|
1. Observation (interactions between physicians and MRs) | 16 observations | |
a. Public & private institutes | 4 Public Healthcare Institutions (medical college hospitals) | |
2 private healthcare facilities(doctor’s chamber/private clinic) | ||
b. Pharmacies/drug shops | 10 Drug shops from each site | |
2. In-depth Interview | ||
a. Authorities | 5 Authorities(DGDA, BMDC, BIRDEM, Ibrahim Medical College, CAB) | |
b. Doctors | 14 Doctors | |
• 3 upazila health complexes (1 from each site) • 3 district hospitals (1 from each site) • 3 divisional medical college hospitals (1 from each site) • 5 private healthcare facilities(doctors chamber/private clinic, 1 from each division | ||
c. Pallichikitshoks (PCs, village doctors) | 8 Pallichikitshoks (PCs, village doctors) | |
d. MRs | 11 MRs (Interviews wereconducted with MRs of variouspharmaceutical companies, both local and multinational) | |
3. Round-table discussion | Participants from pharmaceutical companies: | |
13 participants (CEO, MD, ED, sales manager/senior marketing manager/Director Marketing, manager medical affairs etc.) from 10 renowned pharmaceutical companies | ||
Other Participants: | ||
2 academicians (asst. professor of pharmacy and PhD student, pharmaceutical law and marketing) | ||